Brian Nagel, Oppenheimer retail analyst, joins 'Closing Bell' to discuss the retail picture going into holiday shopping ...

Skip and Esther Oppenheimer have a remarkable legacy of service, advocacy, and philanthropy and helped enrich the lives of ...

Oppenheimer analysts recommend investors to buy the Invesco Small-Cap Momentum ETF (NYSEARCA:XSMO). This index “is one of the ...

Wicked” and “Gladiator II” both drew less in Thursday previews than their “Barbenheimer” counterparts, but are still expected ...

From Following to Oppenheimer, arguably the greatest director of the 21st century has a filmography few can touch ...

We recently compiled a list of the 15 Buzzing AI Stocks Making Headlines. In this article, we are going to take a look at ...

Christopher Nolan has confessed having troubles understanding one aspect of Dune: Part Two, however he did love the film.

We recently compiled a list of the 15 Buzzing AI Stocks Making Headlines. In this article, we are going to take a look at ...

Wicked” and “Gladiator II” didn’t outperform “Barbie” and “Oppenheimer,” but that doesn’t mean it was a bad weekend at the ...

The Joint ICTP-IAEA Nuclear Stakeholder Engagement School’s opening day concluded with a panel discussion, which was open to the public, on opportunities and challenges in expanding the use of nuclear ...

These war movies are all fairly serious, but might be just what the doctor ordered following a heavy Thanksgiving meal.

On Wednesday, Celularity Inc (CELU) stock saw a decline, ending the day at $2.01 which represents a decrease of $-0.84 or -29.47% from the prior close of $2.85. The stock opened at $2.85 and touched a ...